Evidence map›Paper›PMID 40000803›Full record

ArticleNature neuroscience2025

Neuronal polyunsaturated fatty acids are protective in ALS/FTD.

Ashling Giblin, Alexander J Cammack, Niek Blomberg, Sharifah Anoar, Alla Mikheenko, Mireia Carcolé, Magda L Atilano, Alex Hull, Dunxin Shen, Xiaoya Wei and 13 more

Erratum issuedAbstract read
In one paragraph

Article in Nature neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Brain communications · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Ashling Giblin *UK Dementia Research Institute, UCL, London, UK.ORCID http://orcid.org/0000-0001-8470-7908
Alexander J Cammack *UK Dementia Research Institute, UCL, London, UK.
Niek BlombergCenter for Proteomics & Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Sharifah AnoarInstitute of Healthy Ageing, UCL, London, UK.
Alla MikheenkoUK Dementia Research Institute, UCL, London, UK.ORCID http://orcid.org/0000-0003-3400-9719
Mireia CarcoléUK Dementia Research Institute, UCL, London, UK.ORCID http://orcid.org/0000-0001-5054-9016
Magda L AtilanoInstitute of Healthy Ageing, UCL, London, UK.ORCID http://orcid.org/0000-0002-3819-2023
Alex HullInstitute of Healthy Ageing, UCL, London, UK.ORCID http://orcid.org/0000-0002-9700-4926
Dunxin ShenInstitute of Healthy Ageing, UCL, London, UK.
Xiaoya WeiInstitute of Healthy Ageing, UCL, London, UK.
Rachel ConeysUK Dementia Research Institute, UCL, London, UK.
Lele ZhouUK Dementia Research Institute, UCL, London, UK.
Yassene MohammedCenter for Proteomics & Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-3265-3332
Damien Olivier-JimenezCenter for Proteomics & Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-6363-0857
Lian Y WangCenter for Proteomics & Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Kerri J KinghornInstitute of Healthy Ageing, UCL, London, UK.
Teresa NiccoliInstitute of Healthy Ageing, UCL, London, UK.ORCID http://orcid.org/0000-0001-9337-0411
Alyssa N CoyneDepartment of Neurology, Johns Hopkins University, Baltimore, MA, USA.ORCID http://orcid.org/0000-0002-3658-5325
Rik van der KantAlzheimer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Tammaryn LashleyDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.ORCID http://orcid.org/0000-0001-7389-0348
Martin GieraCenter for Proteomics & Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-1684-1894
Linda PartridgeInstitute of Healthy Ageing, UCL, London, UK. l.partridge@ucl.ac.uk.ORCID http://orcid.org/0000-0001-9615-0094
Adrian M IsaacsUK Dementia Research Institute, UCL, London, UK. a.isaacs@ucl.ac.uk.ORCID http://orcid.org/0000-0002-6820-5534

Funding

Mechanisms of impaired ESCRT-III nuclear surveillance in ALS/FTDR01NS132836 · NINDS · JOHNS HOPKINS UNIVERSITY · PI Alyssa Coyne · 2023 to 2026
$2.3M
Mechanisms of nuclear pore complex homeostasis and injury in ALS/FTD and related neurodegenerative diseasesR00NS123242 · NINDS · JOHNS HOPKINS UNIVERSITY · PI COYNE, ALYSSA · 2022 to 2024
$747k
Mechanisms of nuclear pore complex homeostasis and injury in ALS/FTD and related neurodegenerative diseasesK99NS123242 · NINDS · JOHNS HOPKINS UNIVERSITY · PI COYNE, ALYSSA · 2021 to 2021
$130k
NINDS NIH HHS K99 NS123242NINDS NIH HHS R00 NS123242NINDS NIH HHS R01 NS132836U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS123242U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS132836
6 · The paper itself

Abstract

Here we report a conserved transcriptomic signature of reduced fatty acid and lipid metabolism gene expression in a Drosophila model of C9orf72 repeat expansion, the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD), and in human postmortem ALS spinal cord. We performed lipidomics on C9 ALS/FTD Drosophila, induced pluripotent stem (iPS) cell neurons and postmortem FTD brain tissue. This revealed a common and specific reduction in phospholipid species containing polyunsaturated fatty acids (PUFAs). Feeding C9 ALS/FTD flies PUFAs yielded a modest increase in survival. However, increasing PUFA levels specifically in neurons of C9 ALS/FTD flies, by overexpressing fatty acid desaturase enzymes, led to a substantial extension of lifespan. Neuronal overexpression of fatty acid desaturases also suppressed stressor-induced neuronal death in iPS cell neurons of patients with both C9 and TDP-43 ALS/FTD. These data implicate neuronal fatty acid saturation in the pathogenesis of ALS/FTD and suggest that interventions to increase neuronal PUFA levels may be beneficial.

Indexed as

Amyotrophic Lateral SclerosisFatty Acids, UnsaturatedFrontotemporal DementiaNeuronsAnimalsAnimals, Genetically ModifiedBrainC9orf72 ProteinDisease Models, AnimalDrosophilaFatty Acid DesaturasesHumansInduced Pluripotent Stem CellsMaleC9orf72 ProteinFatty Acid DesaturasesFatty Acids, Unsaturated

Identifiers

PMID40000803
PMCPMC11976277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.